Employing the same 2D transwell model of the BBB, the crossing of transferrin - used here as a previously validated negative control for macropinocytosis-dependent transcellular crossing43 - was examined 8 h, 12 h and 16 h post treatment with AML. Here, TF is linked to acute myeloid leukemia.